APA

Tachibana S., Fujimaki Y., Yokoyama H., Okazaki O. & Sudo K. (20060804). In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Tachibana Shuko, Fujimaki Yuko, Yokoyama Hiroyuki, Okazaki Osamu and Sudo Ken-ichi. 20060804. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Tachibana S., Fujimaki Y., Yokoyama H., Okazaki O. and Sudo K. (20060804). In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Tachibana Shuko, Fujimaki Yuko, Yokoyama Hiroyuki, Okazaki Osamu and Sudo Ken-ichi. In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions. : Drug metabolism and disposition: the biological fate of chemicals. 20060804.